DaVita's Innovation in Kidney Care: Supporting KCC Model for Improved Patient Outcomes
- DaVita supports the extension of the Kidney Care Choices Model, enhancing value-based care and patient engagement.
- The KCC Model has allowed DaVita to double its Kidney Contracting Entities, improving patient outcomes and access to services.
- DaVita serves 282,000 patients, focusing on reducing hospitalizations and costs while advancing kidney health care innovations.
DaVita's Commitment to Kidney Care Innovation
DaVita Inc., a leader in kidney care, strongly supports the Center for Medicare and Medicaid Innovation’s (CMMI) recent decision to extend the Kidney Care Choices (KCC) Model for another year. This model aligns with DaVita's long-standing commitment to value-based care, a strategy the company has championed for two decades. Misha Palecek, DaVita's chief transformation officer, emphasizes that the KCC Model is vital for promoting comprehensive and collaborative care, which is essential for improving patient engagement and health outcomes. The extension of this initiative allows DaVita to continue driving innovation in kidney care and further enhance the overall health of patients.
The KCC Model has created a framework for DaVita to double its efforts in value-based care arrangements, expanding from 11 to 22 Kidney Contracting Entities (KCEs) since its inception. These arrangements focus on enhancing the quality of care through coordination and support, which has led to notable improvements in patient outcomes. Reports indicate that the KCC Model has significantly increased kidney transplants, improved access to dialysis services, and elevated the number of patients receiving home dialysis. These advancements reflect DaVita's commitment to not only meet but exceed the evolving needs of the kidney care community.
As of March 31, 2025, DaVita serves around 282,000 patients through its network of 3,173 outpatient dialysis centers worldwide, with the majority situated in the United States. The company's initiatives have resulted in fewer hospitalizations and better mortality rates, showcasing their effectiveness in enhancing patient health while simultaneously reducing healthcare costs. DaVita is dedicated to transforming the kidney health journey, focusing on every aspect from disease progression to transplantation and home dialysis, and their ongoing support for the KCC Model underscores their leadership in advancing high-quality kidney care.
In addition to their support for the KCC Model, DaVita continues to innovate within the kidney care space. The company is actively promoting integrated kidney care programs that encompass a holistic approach to patient management. By prioritizing patient-centered strategies, DaVita aims to set new standards for quality care across the kidney health continuum.
Related Cashu News

Merit Medical Systems Launches Employee Stock Ownership Plan to Boost Engagement and Stability
Merit Medical Systems (Ticker: MMSI) recently takes a significant step in enhancing its employee engagement and ownership structure with the launch of a new Employee Stock Ownership Plan (ESOP). The c…

Brookdale Senior Living launches second season of educational podcast "The Grey Take.
Brookdale Senior Living (Ticker: BKD) launches the second season of its popular podcast, "The Grey Take," which serves as a valuable resource for families exploring senior living options. The podcast…

Molina Healthcare Gains Momentum with Increased Risk Adjustment Payments and Positive Revenue Outlook
Molina Healthcare (Ticker: MOH) is making significant strides in its revenue outlook due to recently released risk adjustment figures from the Centers for Medicare & Medicaid Services (CMS). These upd…

Align Technology Faces Antitrust Investigation by European Commission Over Competitive Practices
Align Technology Inc. (Ticker: ALGN) faces a formal antitrust investigation from the European Commission, marking a significant development in the medical devices sector. This inquiry arises from a co…

